Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement: A Review of Aortic Stenosis Management

Yasar Sattar; Hiba Rauf; Syeda Beenish Bareeqa; Waqas Ullah; Madhura Myla

doi:10.7759/cureus.6431

Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement: A Review of Aortic Stenosis Management

Cureus. 2019 Dec 20;11(12):e6431. doi: 10.7759/cureus.6431.

Authors

Yasar Sattar¹, Hiba Rauf², Syeda Beenish Bareeqa³, Waqas Ullah⁴, Madhura Myla⁵

Affiliations

¹ Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
² Internal Medicine, Dow Medical College, Karachi, PAK.
³ Internal Medicine, Jinnah Medical and Dental College, Karachi, PAK.
⁴ Internal Medicine, Abington Hospital - Jefferson Health, Abington, USA.
⁵ Cardiovascular Disease, University of New Mexico Health Sciences Center, Albuquerque, USA.

Abstract

Severe aortic stenosis (AS) affects 3.4% of the elderly over 60 years of age. It presents with exertional dyspnea, syncope, angina, and progression to irreversible congestive heart failure. Early intervention produces a better outcome in preventing the clinical deterioration of AS. The choice of intervention is transcatheter aortic valve implantation or surgical aortic valve replacement (SAVR). The decision should be made after evaluating an individual case based on its clinical features and the user's experience with transcatheter aortic valve replacement (TAVR). We reviewed available data to illustrate the types of ASs, the background of interventions, current guidelines for TAVR, and its comparison with SAVR in terms of adverse effects.

Keywords: severe aortic stenosis; surgical aortic valve replacement; transcatheter aortic valve implantation; transcatheter aortic valve replacement (tavr).

Publication types

Review